_id
6911be4dccc777a4e85d62b5
Ticker
GNLX
Name
Genelux Corporation Common Stock
Exchange
NASDAQ
Address
2625 Townsgate Road, Westlake Village, CA, United States, 91361
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.genelux.com
Description
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and peritoneal mesothelioma. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Last Close
4.41
Volume
73021
Current Price
2.85
Change
0.19
Last Updated
2026-01-03T12:47:46.287Z
Image
data:image/webp;base64,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
Ipo Date
2023-01-26T00:00:00.000Z
Market Cap
173135568
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7855
Sentiment Sources
2
Rating
4.6
Target Price
19.3333
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
8194000
Operating Income
-8194000
Interest Expense
-
Pretax Income
-7950000
Net Income
-7950000
Eps
-0.20979954405676948
Dividends Per Share
-
Shares Outstanding
38051771
Income Tax Expense
-
EBITDA
-7806000
Operating Margin
-
Total Other Income Expense Net
244000
Cash
4692000
Short Term Investments
16223000
Receivables
-
Inventories
-
Total Current Assets
21552000
Property Plant Equipment
3312000
Total Assets
24987000
Payables
3987000
Short Term Debt
354000
Long Term Debt
-
Total Liabilities
6396000
Equity
18591000
Bs_currency_symbol
USD
Depreciation
144000
Change In Working Capital
-1376000
Cash From Operations
-6575000
Capital Expenditures
517000
Cash From Investing
4721000
Cash From Financing
0
Net Change In Cash
-1854000
Cf_currency_symbol
USD
PE
-
PB
5.809044424721639
ROE
-42.762627077618205
ROA
-31.81654460319366
FCF
-7092000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
8194000
Quarters > 0 > income Statement > operating Income
-8194000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-7950000
Quarters > 0 > income Statement > net Income
-7950000
Quarters > 0 > income Statement > eps
-0.20979954405676948
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
37893314
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7806000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
244000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4692000
Quarters > 0 > balance Sheet > short Term Investments
16223000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
21552000
Quarters > 0 > balance Sheet > property Plant Equipment
3312000
Quarters > 0 > balance Sheet > total Assets
24987000
Quarters > 0 > balance Sheet > payables
3987000
Quarters > 0 > balance Sheet > short Term Debt
354000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6396000
Quarters > 0 > balance Sheet > equity
18591000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-7950000
Quarters > 0 > cash Flow > depreciation
144000
Quarters > 0 > cash Flow > change In Working Capital
-1376000
Quarters > 0 > cash Flow > cash From Operations
-6575000
Quarters > 0 > cash Flow > capital Expenditures
517000
Quarters > 0 > cash Flow > cash From Investing
4721000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-1854000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.20979954405676948
Quarters > 0 > ratios > PB
5.809044424721639
Quarters > 0 > ratios > ROE
-42.762627077618205
Quarters > 0 > ratios > ROA
-31.81654460319366
Quarters > 0 > ratios > FCF
-7092000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
143000
Quarters > 1 > income Statement > gross Profit
-143000
Quarters > 1 > income Statement > operating Expenses
7649000
Quarters > 1 > income Statement > operating Income
-7792000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-7456000
Quarters > 1 > income Statement > net Income
-7456000
Quarters > 1 > income Statement > eps
-0.19648803981834342
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
37946330
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-7313000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
336000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6546000
Quarters > 1 > balance Sheet > short Term Investments
21426000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
29235000
Quarters > 1 > balance Sheet > property Plant Equipment
2939000
Quarters > 1 > balance Sheet > total Assets
32247000
Quarters > 1 > balance Sheet > payables
6033000
Quarters > 1 > balance Sheet > short Term Debt
345000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8349000
Quarters > 1 > balance Sheet > equity
23898000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-7456000
Quarters > 1 > cash Flow > depreciation
-174000
Quarters > 1 > cash Flow > change In Working Capital
-1211000
Quarters > 1 > cash Flow > cash From Operations
-7059000
Quarters > 1 > cash Flow > capital Expenditures
115000
Quarters > 1 > cash Flow > cash From Investing
-2653000
Quarters > 1 > cash Flow > cash From Financing
52000
Quarters > 1 > cash Flow > net Change In Cash
-9660000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.19648803981834342
Quarters > 1 > ratios > PB
4.525359465227216
Quarters > 1 > ratios > ROE
-31.19926353669763
Quarters > 1 > ratios > ROA
-23.121530685024965
Quarters > 1 > ratios > FCF
-7174000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
452000
Quarters > 2 > income Statement > cost Of Revenue
139000
Quarters > 2 > income Statement > gross Profit
-139000
Quarters > 2 > income Statement > operating Expenses
7816000
Quarters > 2 > income Statement > operating Income
-7816000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-7492000
Quarters > 2 > income Statement > net Income
-7492000
Quarters > 2 > income Statement > eps
-0.21451021908416562
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
34926075
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-7677000
Quarters > 2 > income Statement > operating Margin
-1729.2035398230087
Quarters > 2 > income Statement > total Other Income Expense Net
324000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
16206000
Quarters > 2 > balance Sheet > short Term Investments
18896000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
35945000
Quarters > 2 > balance Sheet > property Plant Equipment
2967000
Quarters > 2 > balance Sheet > total Assets
38985000
Quarters > 2 > balance Sheet > payables
6688000
Quarters > 2 > balance Sheet > short Term Debt
337000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
9139000
Quarters > 2 > balance Sheet > equity
29846000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-7492000
Quarters > 2 > cash Flow > depreciation
139000
Quarters > 2 > cash Flow > change In Working Capital
526000
Quarters > 2 > cash Flow > cash From Operations
-5435000
Quarters > 2 > cash Flow > capital Expenditures
30000
Quarters > 2 > cash Flow > cash From Investing
3509000
Quarters > 2 > cash Flow > cash From Financing
9567000
Quarters > 2 > cash Flow > net Change In Cash
7641000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.21451021908416562
Quarters > 2 > ratios > PB
3.3350972910942844
Quarters > 2 > ratios > ROE
-25.102191248408495
Quarters > 2 > ratios > ROA
-19.21764781326151
Quarters > 2 > ratios > FCF
-5465000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-12.09070796460177
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
896000
Quarters > 3 > income Statement > cost Of Revenue
452000
Quarters > 3 > income Statement > gross Profit
-227000
Quarters > 3 > income Statement > operating Expenses
9748000
Quarters > 3 > income Statement > operating Income
-9748000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-8976000
Quarters > 3 > income Statement > net Income
-8976000
Quarters > 3 > income Statement > eps
-0.2853988081102227
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31450727
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-8749000
Quarters > 3 > income Statement > operating Margin
-1087.9464285714287
Quarters > 3 > income Statement > total Other Income Expense Net
772000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
8565000
Quarters > 3 > balance Sheet > short Term Investments
22330000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
31548000
Quarters > 3 > balance Sheet > property Plant Equipment
3076000
Quarters > 3 > balance Sheet > total Assets
34716000
Quarters > 3 > balance Sheet > payables
5570000
Quarters > 3 > balance Sheet > short Term Debt
329000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
8442000
Quarters > 3 > balance Sheet > equity
26274000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-8976000
Quarters > 3 > cash Flow > depreciation
227000
Quarters > 3 > cash Flow > change In Working Capital
2890000
Quarters > 3 > cash Flow > cash From Operations
-4302000
Quarters > 3 > cash Flow > capital Expenditures
96000
Quarters > 3 > cash Flow > cash From Investing
6674000
Quarters > 3 > cash Flow > cash From Financing
91000
Quarters > 3 > cash Flow > net Change In Cash
2463000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.2853988081102227
Quarters > 3 > ratios > PB
3.411531245718201
Quarters > 3 > ratios > ROE
-34.16305092486869
Quarters > 3 > ratios > ROA
-25.85551330798479
Quarters > 3 > ratios > FCF
-4398000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-4.908482142857143
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8000
Annuals > 0 > income Statement > cost Of Revenue
903000
Annuals > 0 > income Statement > gross Profit
-895000
Annuals > 0 > income Statement > operating Expenses
30801000
Annuals > 0 > income Statement > operating Income
-31696000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-29869000
Annuals > 0 > income Statement > net Income
-29869000
Annuals > 0 > income Statement > eps
-0.9497077762304191
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
31450727
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-28966000
Annuals > 0 > income Statement > operating Margin
-396200
Annuals > 0 > income Statement > total Other Income Expense Net
1827000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
8565000
Annuals > 0 > balance Sheet > short Term Investments
22330000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
31548000
Annuals > 0 > balance Sheet > property Plant Equipment
3076000
Annuals > 0 > balance Sheet > total Assets
34716000
Annuals > 0 > balance Sheet > payables
5570000
Annuals > 0 > balance Sheet > short Term Debt
329000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8442000
Annuals > 0 > balance Sheet > equity
26274000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-29869000
Annuals > 0 > cash Flow > depreciation
903000
Annuals > 0 > cash Flow > change In Working Capital
751000
Annuals > 0 > cash Flow > cash From Operations
-21228000
Annuals > 0 > cash Flow > capital Expenditures
381000
Annuals > 0 > cash Flow > cash From Investing
-8131000
Annuals > 0 > cash Flow > cash From Financing
28506000
Annuals > 0 > cash Flow > net Change In Cash
-853000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.9497077762304191
Annuals > 0 > ratios > PB
5.446479708076425
Annuals > 0 > ratios > ROE
-113.68272817233766
Annuals > 0 > ratios > ROA
-86.03813803433576
Annuals > 0 > ratios > FCF
-21609000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2701.125
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
170000
Annuals > 1 > income Statement > cost Of Revenue
1018000
Annuals > 1 > income Statement > gross Profit
-848000
Annuals > 1 > income Statement > operating Expenses
23317000
Annuals > 1 > income Statement > operating Income
-24165000
Annuals > 1 > income Statement > interest Expense
3974000
Annuals > 1 > income Statement > pretax Income
-28297000
Annuals > 1 > income Statement > net Income
-28297000
Annuals > 1 > income Statement > eps
-1.1583232218324258
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
24429278
Annuals > 1 > income Statement > income Tax Expense
850105
Annuals > 1 > income Statement > EBITDA
-26457000
Annuals > 1 > income Statement > operating Margin
-14214.705882352942
Annuals > 1 > income Statement > total Other Income Expense Net
-4132000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
9418000
Annuals > 1 > balance Sheet > short Term Investments
13773000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
24203000
Annuals > 1 > balance Sheet > property Plant Equipment
3598000
Annuals > 1 > balance Sheet > total Assets
27893000
Annuals > 1 > balance Sheet > payables
3784000
Annuals > 1 > balance Sheet > short Term Debt
653000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
8420000
Annuals > 1 > balance Sheet > equity
19473000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-28297000
Annuals > 1 > cash Flow > depreciation
1018000
Annuals > 1 > cash Flow > change In Working Capital
-3281000
Annuals > 1 > cash Flow > cash From Operations
-20275000
Annuals > 1 > cash Flow > capital Expenditures
1025000
Annuals > 1 > cash Flow > cash From Investing
-14724000
Annuals > 1 > cash Flow > cash From Financing
44020000
Annuals > 1 > cash Flow > net Change In Cash
9021000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.1583232218324258
Annuals > 1 > ratios > PB
5.708068345914857
Annuals > 1 > ratios > ROE
-145.31402454680838
Annuals > 1 > ratios > ROA
-101.44839206969492
Annuals > 1 > ratios > FCF
-21300000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-125.29411764705883
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
11068000
Annuals > 2 > income Statement > cost Of Revenue
968000
Annuals > 2 > income Statement > gross Profit
10100000
Annuals > 2 > income Statement > operating Expenses
13113000
Annuals > 2 > income Statement > operating Income
-3013000
Annuals > 2 > income Statement > interest Expense
1408000
Annuals > 2 > income Statement > pretax Income
-4107000
Annuals > 2 > income Statement > net Income
-5207000
Annuals > 2 > income Statement > eps
-0.21206778512365054
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
24553470
Annuals > 2 > income Statement > income Tax Expense
1100000
Annuals > 2 > income Statement > EBITDA
-1731000
Annuals > 2 > income Statement > operating Margin
-27.222623780267437
Annuals > 2 > income Statement > total Other Income Expense Net
-1094000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
397000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1892000
Annuals > 2 > balance Sheet > property Plant Equipment
1979000
Annuals > 2 > balance Sheet > total Assets
5531000
Annuals > 2 > balance Sheet > payables
6775000
Annuals > 2 > balance Sheet > short Term Debt
16665000
Annuals > 2 > balance Sheet > long Term Debt
8524000
Annuals > 2 > balance Sheet > total Liabilities
41314000
Annuals > 2 > balance Sheet > equity
-35783000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5207000
Annuals > 2 > cash Flow > depreciation
968000
Annuals > 2 > cash Flow > change In Working Capital
-1691000
Annuals > 2 > cash Flow > cash From Operations
-3571000
Annuals > 2 > cash Flow > capital Expenditures
49000
Annuals > 2 > cash Flow > cash From Investing
-49000
Annuals > 2 > cash Flow > cash From Financing
-478000
Annuals > 2 > cash Flow > net Change In Cash
-4098000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.21206778512365054
Annuals > 2 > ratios > PB
-3.1221051476958332
Annuals > 2 > ratios > ROE
14.551602716373695
Annuals > 2 > ratios > ROA
-94.14210811788102
Annuals > 2 > ratios > FCF
-3620000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.32706902782797254
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
895000
Annuals > 3 > income Statement > gross Profit
-895000
Annuals > 3 > income Statement > operating Expenses
13718000
Annuals > 3 > income Statement > operating Income
-14613000
Annuals > 3 > income Statement > interest Expense
1815000
Annuals > 3 > income Statement > pretax Income
-16378000
Annuals > 3 > income Statement > net Income
-17795000
Annuals > 3 > income Statement > eps
-0.7535329452479871
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
23615424
Annuals > 3 > income Statement > income Tax Expense
1417000
Annuals > 3 > income Statement > EBITDA
-13668000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1765000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4495000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
5822000
Annuals > 3 > balance Sheet > property Plant Equipment
2212000
Annuals > 3 > balance Sheet > total Assets
8126000
Annuals > 3 > balance Sheet > payables
4462000
Annuals > 3 > balance Sheet > short Term Debt
6557000
Annuals > 3 > balance Sheet > long Term Debt
18023000
Annuals > 3 > balance Sheet > total Liabilities
41237000
Annuals > 3 > balance Sheet > equity
-33111000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-16378000
Annuals > 3 > cash Flow > depreciation
895000
Annuals > 3 > cash Flow > change In Working Capital
4083000
Annuals > 3 > cash Flow > cash From Operations
-6585000
Annuals > 3 > cash Flow > capital Expenditures
49000
Annuals > 3 > cash Flow > cash From Investing
-49000
Annuals > 3 > cash Flow > cash From Financing
-270000
Annuals > 3 > cash Flow > net Change In Cash
-6855000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.7535329452479871
Annuals > 3 > ratios > PB
-3.2451505300353354
Annuals > 3 > ratios > ROE
53.74346893781523
Annuals > 3 > ratios > ROA
-218.98843219296086
Annuals > 3 > ratios > FCF
-6634000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.20979954405676948
Valuation > metrics > PB
5.809044424721639
Valuation > final Score
21.909555752783607
Valuation > verdict
93.6% Overvalued
Profitability > metrics > ROE
-42.762627077618205
Profitability > metrics > ROA
-36.88752783964365
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3440374374697434
Risk > metrics > Interest Coverage
-56.90277777777778
Risk > final Score
-168
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.964754664823773
Liquidity > metrics > Quick Ratio
4.964754664823773
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
34.746405347727844
Prev Valuations > 1
46.64902708905716
Prev Valuations > 2
45.88468754281799
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-158
Prev Risks > 1
-109
Prev Risks > 2
-112
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:55:11.460Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.21
Earnings History > 0 > eps Estimate
-0.22
Earnings History > 0 > eps Difference
0.01
Earnings History > 0 > surprise Percent
4.5455
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.2
Earnings History > 1 > eps Estimate
-0.22
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
9.0909
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-06
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.21
Earnings History > 2 > eps Estimate
-0.22
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
4.5455
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.25
Earnings History > 3 > eps Estimate
-0.25
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
0
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.19
Earnings History > 4 > eps Estimate
-0.25
Earnings History > 4 > eps Difference
0.06
Earnings History > 4 > surprise Percent
24
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-15
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.22
Earnings History > 5 > eps Estimate
-0.24
Earnings History > 5 > eps Difference
0.02
Earnings History > 5 > surprise Percent
8.3333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.29
Earnings History > 6 > eps Estimate
-0.23
Earnings History > 6 > eps Difference
-0.06
Earnings History > 6 > surprise Percent
-26.087
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.25
Earnings History > 7 > eps Estimate
-0.19
Earnings History > 7 > eps Difference
-0.06
Earnings History > 7 > surprise Percent
-31.5789
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.2
Earnings History > 8 > eps Estimate
-0.18
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-11.1111
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.23
Earnings History > 9 > eps Estimate
-0.15
Earnings History > 9 > eps Difference
-0.08
Earnings History > 9 > surprise Percent
-53.3333
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.53
Earnings History > 10 > eps Estimate
-0.16
Earnings History > 10 > eps Difference
-0.37
Earnings History > 10 > surprise Percent
-231.25
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-29
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.12
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.12
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-09-19
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.12
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.12
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-06-24
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.16
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.16
Earnings History > 13 > surprise Percent
-
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and peritoneal mesothelioma. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABiotech Genelux to stream CEO and team in live Titan Partners fireside chat Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$19.3333
Analyst Picks
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Genelux Corporation Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.21
EPS Estimate
-0.22
EPS Difference
0.01
Surprise Percent
4.5455%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.